Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia

Overview of attention for article published in BMC Cancer, July 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,519 followers.

RT @smbenlazar: Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia. - PubM…

11 Jul 2019

Reply Repost Favourite

Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia. - PubMed - NCBI https://t.co/rGIkGR7Alz

09 Jul 2019

Reply Repost Favourite

Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia. https://t.co/8TlVz94KYl

06 Jul 2019

Reply Repost Favourite